Mass safe male circumcision: early lessons from a Ugandan urban site - a case study

International Hospital Kampala, Uganda.
The Pan African medical journal 12/2012; 13:88.
Source: PubMed

ABSTRACT It has been proven in several randomized clinical trials that HIV transmission from female to male is reduced by 60% and more among circumcised males. The national target for Uganda by 2015 is to circumcise 4.2 million adult males, an unprecedented number requiring a pragmatic approach and effective model(s) to deliver this target. The objective of the study was to describe early lessons learnt at a start up of a mass safe male circumcision (SMC) program in an urban Ugandan site, implemented through task shifting and a private public partnership approach.
A case study of an urban SMC site in Uganda's capital, Kampala with a catchment population of approximately 0.8 million adult males aged between 15 and 49 years. Client enrollment was voluntary; mobilization was by word of mouth and through the media. Non Physician clinicians (NPC) carried out the majority of the SMCs. The SMC and voluntary counseling and testing (VCT), adverse events (AE) management and follow up were done as per set national guidelines. The supervision was by a public and private service provider. All clients were consented.
A total of 3000 males were circumcised in 27 days spread over four months. The AE rate was 2.1% all AEs were mild and reversible. No deaths occurred. The work rate was 111 SMCs per day. There was sufficient demand for SMC despite minimal mobilization effort. The bulk of the SMC work was successfully carried out by the NPCs.
Private Public Partnership and task shifting approaches were successful at the start up phase and we anticipate will be feasible for the scale up.

Download full-text


Available from: Moses Galukande, Jan 31, 2014
  • Source
    • "As a result of the policy, several strategies including limited offer of free circumcision at public health facilities, mobilization and sensitization of the population have been put in place to up-scale male medical circumcision in Uganda. Furthermore, in light of the research agenda of the policy, several studies (Galukande et al., 2012; Kitara et al., 2013) have also been undertaken to provide evidence based information useful in future programming of circumcision programs or services in the country. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Safe Male Circumcision is a known intervention in prevention of heterosexual HIV acquisition. However, since the roll-out of the male circumcision policy in Uganda, concerns that circumcision may lead to behavior disinhibition are rife. We assess the association between male circumcision, risky sexual behavior and HIV status among Ugandan men. Data are from AIDS Indicator Survey 2011 with 7,969 ever sexually active men aged 15-59 years. The prevalence of circumcision was 28% and most common risky sexual behaviors were; multiple life-time sexual partners, non marital sex and non-use of condoms. Adjusted logistic regression analyses showed that multiple life-time partners, OR=1.47 (95%CI: 1.28-1.68), engagement in non marital sex, OR=1.25 (95%CI: 1.03-1.50), and non-use of condom at such sex were significantly higher among the circumcised. HIV prevalence was lower among the circumcised even with risky sexual behaviors. There is need for continued sensitization on circumcision and re-packaging of the circumcision messages.
    Population Association of America 2014 Annual Meeting, Boston, MA USA; 05/2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The Ugandan Ministry of Health has endorsed voluntary medical male circumcision as an HIV prevention strategy and has set ambitious goals (e.g., 4.2 million circumcisions by 2015). Innovative strategies to improve access for hard to reach, high risk, and poor populations are essential for reaching such goals. In 2009, the Makerere University Walter Reed Project began the first facility-based VMMC program in Uganda in a non-research setting. In addition, a mobile clinic began providing VMMC services to more remote, rural locations in 2011. The primary objective of this study was to estimate the average cost of performing VMMCs in the mobile clinic compared to those performed in health facilities (fixed sites). The difference between such costs is the cost of improving access to VMMC. A micro-costing approach was used to estimate costs from the service provider's perspective of a circumcision. Supply chain and higher-level program support costs are not included. The average cost (US$2012) of resources used per circumcision was $61 in the mobile program ($72 for more remote locations) compared to $34 at the fixed site. Costs for community mobilization, HIV testing, the initial medical exam, and staff for performing VMMC operations were similar for both programs. The cost of disposable surgical kits, the additional upfront cost for the mobile clinic, and additional costs for staff drive the differences in costs between the two programs. Cost estimates are relatively insensitive to patient flow over time. The MUWRP VMMC program improves access for hard to reach, relatively poor, and high-risk rural populations for a cost of $27-$38 per VMMC. Costs to patients to access services are almost certainly less in the mobile program, by reducing out-of-pocket travel expenses and lost time and associated income, all of which have been shown to be barriers for accessing treatment.
    PLoS ONE 03/2015; 10(3):e0119484. DOI:10.1371/journal.pone.0119484 · 3.53 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Modelling, supported by the USAID Health Policy Initiative and UNAIDS, performed in 2011, indicated that Uganda would need to perform 4.2 million medical male circumcisions (MMCs) to reach 80% prevalence. Since 2010 Uganda has completed 380,000 circumcisions, and has set a national target of 1 million for 2013. To evaluate the relative reach and cost-effectiveness of PrePex compared to the current surgical SMC method and to determine the effect that this might have in helping to achieve the Uganda national SMC targets. A cross-sectional descriptive cost-analysis study conducted at International Hospital Kampala over ten weeks from August to October 2012. Data collected during the performance of 625 circumcisions using PrePex was compared to data previously collected from 10,000 circumcisions using a surgical circumcision method at the same site. Ethical approval was obtained. The moderate adverse events (AE) ratio when using the PrePex device was 2% and no severe adverse events were encountered, which is comparable to the surgical method, thus the AE rate has no effect on the reach or cost-effectiveness of PrePex. The unit cost to perform one circumcision using PrePex is $30.55, 35% ($7.90) higher than the current surgical method, but the PrePex method improves operator efficiency by 60%, meaning that a team can perform 24 completed circumcisions compared to 15 by the surgical method. The cost-effectiveness of PrePex, comparing the cost of performing circumcisions to the future cost savings of potentially averted HIV infections, is just 2% less than the current surgical method, at a device cost price of $20. PrePex is a viable SMC tool for scale-up with unrivalled potential for superior reach, however national targets can only be met with effective demand creation and availability of trained human resource.
    PLoS ONE 05/2013; 8(5):e63134. DOI:10.1371/journal.pone.0063134 · 3.53 Impact Factor
Show more